Medication info
JR Glimepiride Tablet

JR Glimepiride Tablet

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Vivozon Pharmaceuticals Co., Ltd.
Appearance
Green elongated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200410897 · Notified 2004.11.05 · Insurance code 658201080

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medication orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. Monotherapy - In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses exceeding 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. Monotherapy - As diabetes control improves during treatment, the amount of this medication needed may decrease. Therefore, dose reduction or discontinuation of this medication may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. Monotherapy - When switching from another oral hypoglycemic agent to this medication, it is recommended to follow the method described under Initial Dosage. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previous medication. Combination therapy - Combination therapy of this medication with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. Combination therapy - If the patient does not respond adequately to the maximum dose of this medication, addition of metformin may be considered. With combination therapy of this medication and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medication. However, efforts should be made to identify the minimum effective dose of each medication for glycemic control.

Ingredients

Manufacturer
Vivozon Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication aids in improving blood sugar control in patients with type 2 diabetes alongside dietary and exercise regimens. While it can be used alone, it may also be combined with other diabetes medications as needed. For instance, if sufficient blood sugar control isn't achieved with oral hypoglycemic agents, insulin can be used in conjunction with this medication. Moreover, if sufficient effectiveness is not obtained with sulfonylureas or metformin monotherapy, this medication can be administered along with metformin. This helps optimize blood sugar control for effective treatment.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medication orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. Monotherapy - In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses exceeding 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. Monotherapy - As diabetes control improves during treatment, the amount of this medication needed may decrease. Therefore, dose reduction or discontinuation of this medication may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. Monotherapy - When switching from another oral hypoglycemic agent to this medication, it is recommended to follow the method described under Initial Dosage. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previous medication. Combination therapy - Combination therapy of this medication with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. Combination therapy - If the patient does not respond adequately to the maximum dose of this medication, addition of metformin may be considered. With combination therapy of this medication and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medication. However, efforts should be made to identify the minimum effective dose of each medication for glycemic control.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Additionally, patients allergic to this medication or its components, sulfonylureas, or sulfonamide medications should not be prescribed this medication. This medication has not been used in patients with severe liver or kidney dysfunction, thus insulin treatment is recommended in such cases. Women who are pregnant, possibly pregnant, or breastfeeding should also refrain from taking this medication, and it's recommended to switch to insulin therapy as needed. Patients with severe infections or those undergoing surgery, or those experiencing severe trauma should receive insulin therapy instead of this medication. Patients with gastrointestinal issues such as diarrhea or vomiting should be cautious due to the risk of hypoglycemia from poor food absorption. During the first week of treatment, the risk of hypoglycemia is higher, so blood glucose should be monitored closely, especially for the elderly, those in poor nutritional status, patients who skip or have irregular meals, and those who frequently consume alcohol. Patients with decreased renal or hepatic function, other concurrent conditions, or taking other medications should consult their physician as they may be at increased risk for hypoglycemia, and dosage adjustments may be necessary. Symptoms of hypoglycemia, such as headache, severe hunger, nausea, fatigue, confusion, dizziness, may occur, and if these symptoms arise, immediate intake of sugar and consultation with a physician is required. Furthermore, there may be changes in vision, gastrointestinal discomfort, liver dysfunction, blood abnormalities, allergic reactions, so any unusual symptoms should be reported to a healthcare professional immediately. This medication should be taken regularly and along with dietary and exercise regimens, and it’s advisable to always keep sugar on hand to reduce the likelihood of hypoglycemic episodes. Co-administration with other medications may affect blood glucose control, so if starting or stopping any medications, healthcare professionals should be informed. Pregnant or breastfeeding women should avoid this medication and switch to insulin therapy, and the safety and efficacy in children under 18 years have not been established. Elderly patients should be cautious in adjusting the dosage considering renal function. In cases of overdose, hypoglycemia can be severe, so immediate medical attention is needed for appropriate treatment, which may include induced vomiting, gastric lavage, or intravenous dextrose.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language impairment, aphasia, visual impairment, tremor, incomplete paralysis, perceptual abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, phototoxic reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Green elongated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.